These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 4045556

  • 1. Technetium-99m APD compared with technetium-99m MDP as a bone scanning agent.
    Degrossi OJ, Oliveri P, García del Río H, Labriola R, Artagaveytía D, Degrossi EB.
    J Nucl Med; 1985 Oct; 26(10):1135-9. PubMed ID: 4045556
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Measurement of 24-hr whole-body retention of 99mTc-MDP with a thyroid uptake probe (author's transl)].
    Seto H, Kakishita M, Futatsuya R.
    Radioisotopes; 1981 May; 30(5):263-7. PubMed ID: 6458840
    [Abstract] [Full Text] [Related]

  • 4. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U, Kleinhans E, Zorn-Bopp E, Reuschel W, Muenzing W, Moser EA, Seiderer M.
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [Abstract] [Full Text] [Related]

  • 5. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
    Godart G, Durez M, Bevilacqua M, Abramovici J, Robience Y.
    Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
    [Abstract] [Full Text] [Related]

  • 6. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP.
    Knop J, Stritzke P, Kröger E, Schneider C, Wasmus G.
    Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
    Vilcek S, Kalincák M, Machán V.
    Nuklearmedizin; 1981 Dec; 20(6):283-9. PubMed ID: 6460222
    [Abstract] [Full Text] [Related]

  • 13. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
    Wang TS, Fawwaz RA, Johnson LJ, Mojdehi GE, Johnson PM.
    J Nucl Med; 1980 Aug; 21(8):767-70. PubMed ID: 7400832
    [Abstract] [Full Text] [Related]

  • 14. A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases.
    Pauwels EK, Blom J, Camps JA, Hermans J, Rijke AM.
    Eur J Nucl Med; 1983 Aug; 8(3):118-22. PubMed ID: 6220908
    [Abstract] [Full Text] [Related]

  • 15. Measurement of 24-hour whole-body retention of Tc-99mMDP with a thyroid uptake probe: quantitative assessment of metabolic and metastatic bone diseases.
    Seto H, Futatsuya R, Ihara F, Kamei T, Furumoto N, Ishizaki Y, Hada M, Kakishita M.
    Radiat Med; 1984 Aug; 2(2):87-92. PubMed ID: 6240671
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation of 113mIn-DTPMP and 99mTc-MDP for bone scanning].
    Yang JS.
    Zhonghua Fang She Xue Za Zhi; 1984 Feb; 18(1):58-62. PubMed ID: 6236062
    [No Abstract] [Full Text] [Related]

  • 17. Subacute and chronic bone infections: diagnosis using In-111, Ga-67 and Tc-99m MDP bone scintigraphy, and radiography.
    Al-Sheikh W, Sfakianakis GN, Mnaymneh W, Hourani M, Heal A, Duncan RC, Burnett A, Ashkar FS, Serafini AN.
    Radiology; 1985 May; 155(2):501-6. PubMed ID: 3157204
    [Abstract] [Full Text] [Related]

  • 18. [Whole-body retention of 99mTc-methylene diphosphonate in skeletal diseases].
    Zorn-Bopp E, Büll U, Münzing W, Lang P, Moser EA.
    Nuklearmedizin; 1983 Feb; 22(1):24-30. PubMed ID: 6223277
    [Abstract] [Full Text] [Related]

  • 19. [Biokinetics of osteotropic radiopharmaceuticals in metabolic osteopathy--comparison of 47Ca and 99mTc-methylene-diphosphonate (MDP)].
    Knop J, Montz R.
    Nuklearmedizin; 1983 Oct; 22(5):226-31. PubMed ID: 6228781
    [Abstract] [Full Text] [Related]

  • 20. Technetium-99m-MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99m-MDP.
    Caner B, Kitapçl M, Unlü M, Erbengi G, Calikoğlu T, Göğüş T, Bekdik C.
    J Nucl Med; 1992 Mar; 33(3):319-24. PubMed ID: 1531501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.